White; Catherine M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for White; Catherine M..The latest application filed is for "novel substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (ido) inhibitors".

Company Profile

8.10.9

White; Catherine M. - Newton Center MA US
White; Catherine M. - Boston MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,319,295 - White , et al. May 3, 2	2022-05-03
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,319,283 - McGowan , et al. May 3, 2	2022-05-03
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,111,232 - White , et al. September 7, 2	2021-09-07
Novel Substituted Cyclobutylpyridine And Cyclobutylpyrimidine Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200290996 - White; Catherine M. ; et al.	2020-09-17
Novel Substituted Cyclobutylbenzene Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200277252 - McGowan; Meredeth Ann ; et al.	2020-09-03
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 10,745,364 - Aicher , et al. A	2020-08-18
Novel Substituted Phenyloxetane And Phenyltetrahydrofuran Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200239423 - White; Catherine M. ; et al.	2020-07-30
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE App 20190292159 - Aicher; Thomas D. ; et al.	2019-09-26
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 10,377,768 - Aicher , et al. A	2019-08-13
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 10,221,146 - Aicher , et al.	2019-03-05
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20180030005 - Aicher; Thomas D. ; et al.	2018-02-01
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 9,809,561 - Aicher , et al. November 7, 2	2017-11-07
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20170313722 - Aicher; Thomas D. ; et al.	2017-11-02
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease Grant 9,657,033 - Aicher , et al. May 23, 2	2017-05-23
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20160304476 - Aicher; Thomas D. ; et al.	2016-10-20
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20150111877 - Aicher; Thomas D. ; et al.	2015-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.